Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Are defensive sectors ready to outshine growth in 2024?: https://www.marketbeat.com/logos/articles/med_20240105132256_are-defensive-sectors-ready-to-outshine-growth-in.jpg
Are defensive sectors ready to outshine growth in 2024?

Defensive sectors are off to a better start to the new year than growth stocks, which dominated in 2023. 

The Health Care Select Sector SPDR Fund (NYSEARCA: XLV), which has both growth and

This biotech stock has surged over 300% this week: https://www.marketbeat.com/logos/articles/med_20240105071140_this-biotech-stock-has-surged-over-300-this-week.jpg
This biotech stock has surged over 300% this week

As the market continues to witness a resurgence in small-cap investments, led by a jump in investor optimism and speculation, there’s been a seemingly steady flow of capital back into

The 5 top-rated dividend stocks by analysts: https://www.marketbeat.com/logos/articles/med_20240104133044_chart-bip142023ver001.png
The 5 top-rated dividend stocks by analysts

Marketbeat.com provides many tools for investors, including analyst-tracking algorithms. A single upgrade is worthless, but a trend of upgrades can repeatedly drive a stock to new highs. Today

Can Coinbase stock still rally another 50% from here?: https://www.marketbeat.com/logos/articles/med_20240104140221_chart22-coin.jpg
Can Coinbase stock still rally another 50% from here?

Coinbase Global Inc. (NASDAQ: COIN) is the largest publicly traded cryptocurrency exchange in the U.S. It is arguably the most trusted and stable exchange due to its regulatory transparency and

Will the Biotech sector sustain its momentum in 2024?: https://www.marketbeat.com/logos/articles/med_20240104092418_will-the-biotech-sector-sustain-its-momentum-in-20.jpg
Will the Biotech sector sustain its momentum in 2024?

The stock market is like a bustling stage, and on the first trading day of the year, one performer stole the show while others struggled to keep up. 

The iShares Biotechnology ETF (NASDAQ: IBB)

Is Netflix stock a buy ahead of January earnings?: https://www.marketbeat.com/logos/articles/med_20240104083945_is-netflix-stock-a-buy-ahead-of-january-earnings.jpg
Is Netflix stock a buy ahead of January earnings?

Even though a 75% drop through 2022 may have disqualified Netflix Inc (NASDAQ: NFLX) from the previously untouchable FAANG group of tech stocks, the current rally of nearly 200% has certainly put

It's official, BYD has overtaken Tesla as the EV king: https://www.marketbeat.com/logos/articles/med_20240104075420_its-official-byd-has-overtaken-tesla-as-the-ev-kin.jpeg
It's official, BYD has overtaken Tesla as the EV king

What a time to be an investor; there are changes coming left and right to those who call the stock market home to their savings or spare cash to be invested. The intellectual challenge is enough

Analysts expect Bank of America stock to rally 55%: https://www.marketbeat.com/logos/articles/med_20240104075013_analysts-expect-bank-of-america-stock-to-rally-55.jpg
Analysts expect Bank of America stock to rally 55%

A 35% rally since October meant that Bank of America (NYSE: BAC) shares finished the year on a high after what was, at best, turning into a mediocre year before that. Shares of the Wall Street

3 ways to trade options if you believe a stock will fall lower: https://www.marketbeat.com/logos/articles/med_20240103120548_intcstock.jpg
3 ways to trade options if you believe a stock will fall lower

If you believe that a stock is going to fall lower in price, then there are three kinds of options trades you can make to capitalize on the move potentially. You don't necessarily have to be a

3 mid-cap stocks that analysts love heading into earnings season: https://www.marketbeat.com/logos/articles/med_20240103120724_3-mid-cap-stocks-that-analysts-love-heading-into-e.jpg
3 mid-cap stocks that analysts love heading into earnings season

The beginning of a new year also means that a new earnings season is right around the corner. Every earnings season seems "the most important earnings season" for investors. But when every stock

Starbucks stock is suddenly surrounded by analysts: https://www.marketbeat.com/logos/articles/med_20240103104020_starbucks-stock-is-suddenly-surrounded-by-analysts.jpg
Starbucks stock is suddenly surrounded by analysts

The answer everyone is looking for in today's market is one that potentially positions portfolios in a way to benefit from the coming FED interest rate cuts in 2024. Because markets are

UniFirst stock falls into the buy zone: https://www.marketbeat.com/logos/articles/med_20240103094647_chart-unf-132023ver001.png
UniFirst stock falls into the buy zone

UniFirst (NYSE: UNF) had a decent first quarter but provided weak guidance, sending shares down nearly 10%. As bad as the move sounds, it’s a knee-jerk reaction in a stock whose future is bright

5 Reasons Under Armour stock may not trade under $10 for long: https://www.marketbeat.com/logos/articles/med_20240103085353_5-reasons-under-armour-stock-may-not-trade-under-1.jpg
5 Reasons Under Armour stock may not trade under $10 for long

On two occasions last year, Under Armour, Inc. (NYSE:UAA) came within pennies of recovering to the $10.00 level. In 2024, the third time may not only be the charm but also unleash an extra large

4 takeaways from the first day of trading in 2024: https://www.marketbeat.com/logos/articles/med_20240103081547_chart-spx-132024ver001.png
4 takeaways from the first day of trading in 2024

The first day of 2024 trading has come and gone, and the signs they sent are not good. Between market leaders confirming a top, the S&P 500 (NYSEARCA: SPY) retreating, and the VIX (NDEXCBOE: VIX)

Intel stock: Analysts are expecting multi-year highs: https://www.marketbeat.com/logos/articles/med_20240103075306_intel-stock-analysts-are-expecting-multi-year-high.jpg
Intel stock: Analysts are expecting multi-year highs

After falling more than 50% in 2022, last year really was all about the recovery for shares of Intel Corporation (NASDAQ: INTC). They climbed throughout the year, finishing up about 100% from

Traders are suddenly stampeding these Buffett stocks: https://www.marketbeat.com/logos/articles/med_20240102191321_traders-are-suddenly-stampeding-these-buffett-stoc.jpg
Traders are suddenly stampeding these Buffett stocks

The new year is here, and some are already calling the shots about how 2024 could look. Who dominates? It will likely experience a 'trader' market in the first quarter of 2024, considering where

AT&T could be the best placeholder stock before rate cuts come: https://www.marketbeat.com/logos/articles/med_20240102190745_att-could-be-the-best-placeholder-stock-before-rat.jpg
AT&T could be the best placeholder stock before rate cuts come

A significant shift is about to come to the financial markets, as the forces that push and pull stock prices are pivoting from one end to the opposite in the coming months. Interest rates act as a

Will cost cuts be enough for Hasbro to thrive in 2024?: https://www.marketbeat.com/logos/articles/med_20231231120706_chartt-has.jpg
Will cost cuts be enough for Hasbro to thrive in 2024?

Global toy and entertainment company Hasbro Inc. (NYSE: HAS) had a weak 2023 as shares fell 17.5% compared to the 24.8% gain for the S&P 500 index. It also underperformed rival Mattel Inc. (NYSE:

Eilt: Biotech Hot Stock 2024 heilt Hautkrebs vollständig - Massives Kaufsignal. 297% Biotech Aktientip nach 134.452% mit Biogen. Massives Kaufsignal. Jetzt 359% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205: https://www.irw-press.at/prcom/images/messages/2024/73150/Aktiencheck030124.001.png
Eilt: Biotech Hot Stock 2024 heilt Hautkrebs vollständig - Massives Kaufsignal. 297% Biotech Aktientip nach 134.452% mit Biogen. Massives Kaufsignal. Jetzt 359% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205

Eilt: Biotech Hot Stock 2024 heilt Hautkrebs vollständig - Kaufsignal. 297% Biotech Aktientip nach 15.973% mit BioNTech

 

03.01.24

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Link

Amprius Technologies amps the market and enters a reversal: https://www.marketbeat.com/logos/articles/med_20240102091233_chart-ampx-122024ver001.png
Amprius Technologies amps the market and enters a reversal

Amprius Technologies (NYSE: AMPX) stock price action over the past year or so is not surprising. It is an early-stage tech start-up whose IPO left little meat on the bone for new investors

Analysts suddenly say Google is the place to be in: https://www.marketbeat.com/logos/articles/med_20240102074605_analysts-suddenly-say-google-is-the-place-to-be-in.jpg
Analysts suddenly say Google is the place to be in

Very few times in history have investors come across a stock that offers the sort of moat that Warren Buffett could salivate over, a strong business with solid financials and a structure

One fast-food stock is expected to outperform all others in 2024: https://www.marketbeat.com/logos/articles/med_20240102074256_one-fast-food-stock-is-expected-to-outperform-all.jpg
One fast-food stock is expected to outperform all others in 2024

With a 20% rally under its belt since October, it goes without saying that McDonald's Corp (NYSE: MCD) is coming into 2024 looking pretty hot. After a disappointing Q3 threatened to spiral out of